glp 1 mimetics GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits GLP-1 mimetics and cognition -

Check out my full report here where I detail the paper trail of how Novo got here and just how massive a market opportunity this is for Hims and others

Such trials can cost hundreds of millions of dollars to run

The meta-analysis included a Danish study [29] showing an increased incidence of prostate cancer during the first two years following initiation of insulin

Patients should be learning how to make these nutrition and lifestyle changes to support their metabolic health and maintain healthy results

Tang H, Lu Y, Okun MS, Donahoo WT, Ramirez-Zamora A, Wang F, Huang Y, Armstrong M, Svensson M, Virnig BA, DeKosky ST, Bian J, Guo J (2024) Glucagon-like Peptide-1 receptor agonists and risk of Parkinsons Disease in patients with type 2 diabetes: a Population-based Cohort Study

Over the past ten years, the use of second-line ADMs has increased significantly